清肺化痰逐瘀汤对AECOPD痰瘀互结证血液流变学的临床研究.pdfVIP

The Blood rheology clinical research with Qing fei hua tan zhu yu decoction treat AECOPD phlegm stasis syndrome Abstract objective: This topic is for the purpose of through tying the card patients clinical research mutually to the Qing fei hua tan zhu yu decoction to the AECOPD phlegm stasis, observes it to the AECOPD patient blood rheology change, appraises the Qing fei hua tan zhu yu decoction to the AECOPD patients therapeutic action, patients clinical care provides the basis for the Qing fei hua tan zhu yu decoction in AECOPD. Methods: With the selection criteria for acute exacerbation of chronic obstructive pulmonary disease) and phlegm stasis syndrome, 60 randomly divided into two groups: control group, 30 cases given oxygen, cefotaximes (cefotaximes allergic to give cefoperazone sulbactam was, or azithromycin), with levofloxacin anti-infection, Breathing, phlegm thick aminophylline shall not give up the hydrochloric acid ammonia bromine cable, 30 cases in treatment group and give the Qing fei hua tan zhu yu decoction by western medicine therapy, cooperate with the soup, To observe the clinical symptoms, groups and routine blood and urine, liver, kidney, chest radiograph (CT), electrocardiogram, pulmonary function and so on security inspection and change of blood rheology. 2 weeks for a course of treatment, observation. After the end of the period of clinical efficacy and safety is evaluated. Results: When carries on the sex, the age, the course, the smoking index, the job category, this sickness morbidity to two group of patients long and so on carries on statistics processing, in two group of patients do not have under the significance difference premise, After Canada with the Qing fei hua tan zhu yu decoction treatment, treats the latter two group of symptom comparison: The treatment group cough, the respite, the vena sublingualis in and out has the obvious difference (P0.05),